What can data mining teach us about triptan safety that we don’t already know?

The authors discuss research on the vascular safety of the antimigraine drug triptan. They reference the study "Triptans and Serious Adverse Vascular Events: Data Mining of the FDA Adverse Event Reporting System Database" by G. Roberto and colleagues published in the current issue of the journal. They believe that the analysis of the database represents a useful complementary source of information about triptan safety.